SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-002123
Filing Date
2023-01-09
Accepted
2023-01-09 10:19:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm232243d1_sc13ga.htm SC 13G/A 34407
  Complete submission text file 0001104659-23-002123.txt   35623
Mailing Address 27 RIPPLEVALE GROVE LONDON X0 N1 1HS
Business Address
Mosseri Marlio Charles (Filed by) CIK: 0001806384 (see all company filings)

Type: SC 13G/A

Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Subject) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93555 | Film No.: 23517003
SIC: 2834 Pharmaceutical Preparations